1. Home
  2. PCVX vs HOMB Comparison

PCVX vs HOMB Comparison

Compare PCVX & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • HOMB
  • Stock Information
  • Founded
  • PCVX 2013
  • HOMB 1998
  • Country
  • PCVX United States
  • HOMB United States
  • Employees
  • PCVX 414
  • HOMB N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • HOMB Major Banks
  • Sector
  • PCVX Health Care
  • HOMB Finance
  • Exchange
  • PCVX Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • PCVX 4.1B
  • HOMB 5.0B
  • IPO Year
  • PCVX 2020
  • HOMB 2006
  • Fundamental
  • Price
  • PCVX $35.02
  • HOMB $28.13
  • Analyst Decision
  • PCVX Strong Buy
  • HOMB Hold
  • Analyst Count
  • PCVX 10
  • HOMB 5
  • Target Price
  • PCVX $136.50
  • HOMB $31.00
  • AVG Volume (30 Days)
  • PCVX 2.5M
  • HOMB 660.9K
  • Earning Date
  • PCVX 05-07-2025
  • HOMB 07-16-2025
  • Dividend Yield
  • PCVX N/A
  • HOMB 2.85%
  • EPS Growth
  • PCVX N/A
  • HOMB 8.29
  • EPS
  • PCVX N/A
  • HOMB 2.09
  • Revenue
  • PCVX N/A
  • HOMB $987,214,000.00
  • Revenue This Year
  • PCVX N/A
  • HOMB $11.25
  • Revenue Next Year
  • PCVX N/A
  • HOMB $2.78
  • P/E Ratio
  • PCVX N/A
  • HOMB $13.46
  • Revenue Growth
  • PCVX N/A
  • HOMB 1.15
  • 52 Week Low
  • PCVX $27.66
  • HOMB $22.42
  • 52 Week High
  • PCVX $121.06
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 52.30
  • HOMB 47.28
  • Support Level
  • PCVX $31.37
  • HOMB $28.09
  • Resistance Level
  • PCVX $33.31
  • HOMB $28.88
  • Average True Range (ATR)
  • PCVX 2.13
  • HOMB 0.44
  • MACD
  • PCVX 0.77
  • HOMB -0.13
  • Stochastic Oscillator
  • PCVX 77.80
  • HOMB 27.60

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: